MedTrace Logo

Innovation Platform

NCT04558528 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 640

Last updated 2023-11-18

No results posted yet for this study

Summary

In this study, a prospective evaluation of novel malaria diagnostic tools under development will be performed in malaria-endemic countries to assess their clinical performance for detection of malaria at point-of-care (POC). This study aims to support product development efforts and aims to provide early stage (TLR\~5) technology developers with valuable information on performance and basic feasibility data that can help to accelerate development.

Conditions

Interventions

DIAGNOSTIC_TEST

Novel in vitro diagnostics and medical applications

Novel in vitro diagnostics and medical applications

Sponsors & Collaborators

  • Foundation for Innovative New Diagnostics, Switzerland

    lead OTHER

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-07-31
Completion
2021-07-31

Countries

  • Indonesia
  • Rwanda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04558528 on ClinicalTrials.gov